[18F]NAV4694

NAV4694 · Navidea Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for [18F]NAV4694, covering 2016-03-30 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI [Phase 2]